• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新接受持续性非卧床腹膜透析患者铁代谢及缺铁情况的评估

Assessment of iron metabolism and iron deficiency in incident patients on incident continuous ambulatory peritoneal dialysis.

作者信息

Yin Qinghua, Guo Na, Fu Ping, Zhong Hui

机构信息

Kidney Research Institute, Division of Nephrology, West China Hospital, Sichuan University, Chengdu 610041, Sichuan, China.

Division of Nephrology, Department of Pediatrics, West China Second Hospital, Sichuan University, Chengdu 610041, Sichuan, China.

出版信息

Open Med (Wars). 2024 Sep 17;19(1):20241035. doi: 10.1515/med-2024-1035. eCollection 2024.

DOI:10.1515/med-2024-1035
PMID:39308920
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11416072/
Abstract

OBJECTIVE

The aim of this study was to investigate iron status and iron deficiency in incident continuous ambulatory peritoneal dialysis (CAPD) patients and identify influencing factors.

METHODS

Patients with end-stage renal disease were enrolled. Clinical data of iron metabolism and biochemical and dialysis parameters during the first peritoneal dialysis evaluation were collected. Serum ferritin (SF) and transferrin saturation (TSAT) levels were evaluated, and independent influencing factors were identified by correlation and regression analyses.

RESULTS

Of 1,128 adult CAPD patients, 41.2% had iron deficiency (ID), 15.7% had absolute iron deficiency, and 8.2% had functional iron deficiency. The average SF level was (276.8 ± 277.9) μg/L, and iron saturation was (29.8 ± 12.7)%. Additionally, 50.2 and 69.3% of patients reached targets in SF level and iron saturation recommended by the Chinese Society of Nephrology. SF level and TSAT were not correlated with estimated glomerular filtration rate, whereas negatively correlated with platelet count and inflammatory factors. Low platelet count, presence of diabetes mellitus and high interleukin 6 levels were independent factors of lower TSAT.

CONCLUSIONS

ID is common in patients with CAPD. Women and those with thrombocytopenia, diabetes, and inflammation are at higher risk for iron storage or reduced iron utilization. In the initial CAPD stage, a reasonable iron supplement strategy may be established for CAPD patients with high-risk factors.

摘要

目的

本研究旨在调查新确诊的持续性非卧床腹膜透析(CAPD)患者的铁状态和缺铁情况,并确定影响因素。

方法

纳入终末期肾病患者。收集首次腹膜透析评估时铁代谢、生化及透析参数的临床资料。评估血清铁蛋白(SF)和转铁蛋白饱和度(TSAT)水平,通过相关性和回归分析确定独立影响因素。

结果

在1128例成年CAPD患者中,41.2%存在缺铁(ID),15.7%为绝对缺铁,8.2%为功能性缺铁。SF平均水平为(276.8±277.9)μg/L,铁饱和度为(29.8±12.7)%。此外,50.2%和69.3%的患者达到了中国肾脏病学会推荐的SF水平和铁饱和度目标。SF水平和TSAT与估计肾小球滤过率无关,而与血小板计数和炎症因子呈负相关。血小板计数低、患有糖尿病和白细胞介素6水平高是TSAT降低的独立因素。

结论

ID在CAPD患者中很常见。女性以及血小板减少、糖尿病和炎症患者铁储存或铁利用减少的风险更高。在CAPD初始阶段,可为有高危因素的CAPD患者制定合理的补铁策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68b4/11416072/c55b332ee82e/j_med-2024-1035-fig002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68b4/11416072/cfe45d8b8695/j_med-2024-1035-fig001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68b4/11416072/c55b332ee82e/j_med-2024-1035-fig002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68b4/11416072/cfe45d8b8695/j_med-2024-1035-fig001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68b4/11416072/c55b332ee82e/j_med-2024-1035-fig002.jpg

相似文献

1
Assessment of iron metabolism and iron deficiency in incident patients on incident continuous ambulatory peritoneal dialysis.新接受持续性非卧床腹膜透析患者铁代谢及缺铁情况的评估
Open Med (Wars). 2024 Sep 17;19(1):20241035. doi: 10.1515/med-2024-1035. eCollection 2024.
2
3
[Anemia in peritoneal dialysis patients].[腹膜透析患者的贫血]
Srp Arh Celok Lek. 2006 Mar-Apr;134(3-4):133-7. doi: 10.2298/sarh0604133l.
4
Parathyroid hormone contributes to variations in blood morphology in diabetic and non diabetic patients treated with continuous ambulatory peritoneal dialysis.甲状旁腺激素在接受持续性非卧床腹膜透析治疗的糖尿病和非糖尿病患者中,对血液形态变化有影响。
Adv Perit Dial. 2001;17:5-9.
5
Critical re-evaluation of the identification of iron deficiency states and effective iron repletion strategies in patients with chronic heart failure.对慢性心力衰竭患者铁缺乏状态的识别和有效补铁策略的重新评估。
Eur J Heart Fail. 2024 Jun;26(6):1298-1312. doi: 10.1002/ejhf.3237. Epub 2024 May 10.
6
Can the inflammation markers of patients with high peritoneal permeability on continuous ambulatory peritoneal dialysis be reduced on nocturnal intermittent peritoneal dialysis?持续性非卧床腹膜透析时腹膜高通透性患者的炎症标志物在夜间间歇性腹膜透析时能否降低?
Perit Dial Int. 2006 May-Jun;26(3):341-8.
7
Use of bolus intraperitoneal iron dextran in continuous ambulatory peritoneal dialysis or continuous cyclic peritoneal dialysis patients receiving recombinant human erythropoietin.在接受重组人促红细胞生成素治疗的持续性非卧床腹膜透析或持续性循环腹膜透析患者中使用大剂量腹腔内右旋糖酐铁。
Adv Perit Dial. 1999;15:60-4.
8
[Intravenous iron sucrose in maintenance dialysis patients with renal anemia: a clinical study].[蔗糖铁静脉注射用于维持性透析肾性贫血患者的临床研究]
Zhonghua Yi Xue Za Zhi. 2009 Feb 24;89(7):457-62.
9
Iron status and anemia control are related to peritoneal membrane properties in peritoneally dialyzed patients.铁状态和贫血控制与腹膜透析患者的腹膜特性相关。
Front Med (Lausanne). 2023 Jul 6;10:1148094. doi: 10.3389/fmed.2023.1148094. eCollection 2023.
10
Serum concentration of haptoglobin, adequacy of peritoneal dialysis, and nutrition status of patients with and without diabetes on peritoneal dialysis.接受和未接受腹膜透析的糖尿病患者的血清触珠蛋白浓度、腹膜透析充分性及营养状况
Adv Perit Dial. 2003;19:246-50.

本文引用的文献

1
Association of Abnormal Iron Status with the Occurrence and Prognosis of Peritoneal Dialysis-Related Peritonitis: A Longitudinal Data-Based 10-Year Retrospective Study.异常铁状态与腹膜透析相关性腹膜炎的发生和预后的关系:一项基于纵向数据的 10 年回顾性研究。
Nutrients. 2022 Apr 13;14(8):1613. doi: 10.3390/nu14081613.
2
Roxadustat Versus Epoetin Alfa for Treating Anemia in Patients with Chronic Kidney Disease on Dialysis: Results from the Randomized Phase 3 ROCKIES Study.罗沙司他对比促红细胞生成素α治疗透析患者慢性肾脏病相关贫血的随机 3 期 ROCKIES 研究结果。
J Am Soc Nephrol. 2022 Apr;33(4):850-866. doi: 10.1681/ASN.2020111638.
3
Iron Deficiency in CKD Without Concomitant Anemia.
慢性肾脏病中无合并贫血的缺铁情况
Kidney Int Rep. 2021 Aug 10;6(11):2752-2762. doi: 10.1016/j.ekir.2021.07.032. eCollection 2021 Nov.
4
Phase 3 Study of Roxadustat to Treat Anemia in Non-Dialysis-Dependant CKD.罗沙司他治疗非透析依赖性慢性肾脏病贫血的3期研究。
Kidney Int Rep. 2021 Apr 17;6(7):1810-1828. doi: 10.1016/j.ekir.2021.04.003. eCollection 2021 Jul.
5
Roxadustat for Treating Anemia in Patients with CKD Not on Dialysis: Results from a Randomized Phase 3 Study.罗沙司他治疗未透析慢性肾脏病患者贫血的随机 3 期研究结果。
J Am Soc Nephrol. 2021 Mar;32(3):737-755. doi: 10.1681/ASN.2020081150. Epub 2021 Feb 10.
6
Phase 3, Randomized, Double-Blind, Active-Comparator (Darbepoetin Alfa) Study of Oral Roxadustat in CKD Patients with Anemia on Hemodialysis in Japan.日本血液透析慢性肾脏病贫血患者罗沙司他的 3 期、随机、双盲、阳性对照(达贝泊汀α)研究。
J Am Soc Nephrol. 2020 Jul;31(7):1628-1639. doi: 10.1681/ASN.2019060623. Epub 2020 Jun 3.
7
Inflammation, but Not the Underlying Disease or Its Location, Predicts Oral Iron Absorption Capacity in Patients With Inflammatory Bowel Disease.炎症而非基础疾病或其部位可预测炎症性肠病患者的口服铁吸收能力。
J Crohns Colitis. 2020 Mar 13;14(3):316-322. doi: 10.1093/ecco-jcc/jjz149.
8
International Anemia Prevalence and Management in Peritoneal Dialysis Patients.国际腹膜透析患者贫血的患病率及管理。
Perit Dial Int. 2019 Nov-Dec;39(6):539-546. doi: 10.3747/pdi.2018.00249. Epub 2019 Oct 3.
9
Etiologies of Extreme Thrombocytosis: A Contemporary Series.极端血小板增多症的病因:当代系列研究。
Mayo Clin Proc. 2019 Aug;94(8):1542-1550. doi: 10.1016/j.mayocp.2019.01.041.
10
Roxadustat Treatment for Anemia in Patients Undergoing Long-Term Dialysis.罗沙司他治疗长期透析患者的贫血。
N Engl J Med. 2019 Sep 12;381(11):1011-1022. doi: 10.1056/NEJMoa1901713. Epub 2019 Jul 24.